France

CJEU landmark ruling confirms that CBD is not a narcotic drug and that member states may not prohibit its marketing

Eveline Van Keymeulen

Today, the Court of Justice of the European Union (CJEU) delivered its long-awaited decision in Case C-663/18 (Kanavape) ruling that a member state may not ban the marketing of cannabidiol (CBD) extracted from the Cannabis sativa plant in its entirety. In today’s judgment, the Court finds that EU law, in particular the provisions on the Read More

France – Covid-19 coronavirus: HAS position on antigenic tests in three clinical situations

Jeanne Fabre

On 25 September 2020, the French National Authority for Health (HAS) issued a favourable opinion on the use of antigenic tests on nasopharyngeal swabs in people who present symptoms of Covid-19. The HAS specified the required performance: a minimum sensitivity of over 80% and a minimum specificity of over 99%. The HAS also acknowledged that Read More

Final parts of new French anti-gift regulation published

Jeanne Fabre

The new French “anti-gift” regulation, supplemented and specified by the decree of 15 June 2020 and the “threshold” decrees of 7 August 2020, has been fully effective since 1 October 2020 (see our previous blog post French anti-gift regulation is now complete!). Further to these texts, the following new orders finalise the regulation and add Read More

French medical cannabis pilot: call for applications for suppliers launched today – responses required by 24 November

Eveline Van Keymeulen

Today, the French National Agency for Medicines and Health Products Safety (ANSM) has officially launched the call for applications (“appel à candidatures”) for medical cannabis suppliers to participate in the pilot programme that will be started by 31 March at the latest.  The call for applications follows the publication of the ministerial order providing the Read More

France: Presentation of 2021 measures for innovative medicines

Jeanne Fabre

On 30 September 2020, the French government published a press release announcing the draft of the French Social Security Financing Bill (PLFSS) for 2021, which it presented as “one of the most singular exercises since the creation of the PLFSS in 1996”. One of the main points of the PLFSS for 2021 is a specific Read More